Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zymeworks Inc. Director's Dealing 2024

Dec 13, 2024

32180_dirs_2024-12-12_0d6e9b6a-20db-4e3b-ab6e-1cdfb135a332.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2024-12-10

Reporting Person: Miller Derek John Michael (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-10 Stock Option (Right to Buy) $13.06 A 31000 Acquired 2034-12-09 Common Stock (31000) Direct

Footnotes

F1: Stock options vest on date of next annual general meeting following grant date of December 10, 2024.